Spain-based biotech venture capital firm, Ysios Capital, has closed its third fund, Ysios BioFund 3 (YBF 3) at €216m (US$264m). Its largest fund to date, YBF 3 will invest across…
Spain-based biotech venture capital firm, Ysios Capital, has closed its third fund, Ysios BioFund 3 (YBF 3) at €216m (US$264m). Its largest fund to date, YBF 3 will invest across…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


